Effects of Anthocyans on Cardiovascular and Sympathetic Function

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00634387

Enrollment

Registered

2008-03-13

Start date

2008-03-31

Completion date

2009-06-30

Last updated

2011-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

Anthocyans modify cardiovascular and sympathetic function

Interventions

DIETARY_SUPPLEMENTAnthocyans

Anthocyans

OTHERplacebo

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

MALE

Age

35 Years to 50 Years

Healthy volunteers

Inclusion criteria

* Ages 35 to 50 years old * Males * Hypertension

Design outcomes

Primary

Measure	Time frame
Systolic bloodpressure and heartrate	—

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026